Skip to main content

Emerging Cancer Therapies Rely On Patient’s Immune System

University of Wisconsin Hospital in Madison has treated two children with acute lymphoblastic leukemia using the recently approved therapy KYMRIAH. One child is very early in the process and another is in remission, said Dr. Mark Juckett, chief of bone marrow transplant at UW Carbone Cancer Center in Madison.